Premium
Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐ TNF medications—authors’ reply
Author(s) -
Khan N.,
Lewis J. D.
Publication year - 2018
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14460
Subject(s) - medicine , inflammatory bowel disease , vaccination , disease , tumor necrosis factor alpha , inflammatory bowel diseases , immunology , dermatology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom